<DOC>
	<DOCNO>NCT00664287</DOCNO>
	<brief_summary>The purpose study test effect MK0524A ( niacin ( + ) laropiprant ) lower bad cholesterol raise good cholesterol .</brief_summary>
	<brief_title>Extended Release ( ER ) Niacin/Laropiprant Add Study ( 0524A-082 )</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Patients 18 year age older stable dose lipid therapy Patients lipid level outside recommended range Patients HIV positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>